Skip to main content
. 2004 Jul 31;329(7460):253. doi: 10.1136/bmj.38149.566979.AE

Fig 2.

Fig 2

Spontaneous pain intensity during one week baseline, last week of active treatment, and last week of placebo treatment. Each line represents one patient. Active-placebo group=patients randomised to active medication in first treatment period (n=12); placebo-active group=patients randomised to placebo in first treatment period (n=12); NRS=numerical rating scale